DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 119 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,064,282 | +18.3% | 72,057 | +3.5% | 0.00% | – |
| Q2 2023 | $899,348 | +763.0% | 69,609 | +555.3% | 0.00% | – |
| Q1 2023 | $104,212 | -19.7% | 10,623 | -13.0% | 0.00% | – |
| Q4 2022 | $129,851 | +0.7% | 12,204 | -1.3% | 0.00% | – |
| Q3 2022 | $129,000 | -11.0% | 12,365 | -7.4% | 0.00% | – |
| Q1 2022 | $145,000 | -43.1% | 13,349 | -26.5% | 0.00% | – |
| Q4 2021 | $255,000 | -91.4% | 18,157 | -97.8% | 0.00% | -100.0% |
| Q3 2019 | $2,981,000 | -74.5% | 833,913 | -71.5% | 0.00% | -66.7% |
| Q2 2019 | $11,683,000 | -50.1% | 2,928,186 | -8.6% | 0.01% | -53.8% |
| Q1 2019 | $23,416,000 | -20.0% | 3,203,308 | +0.1% | 0.01% | -27.8% |
| Q4 2018 | $29,273,000 | -24.7% | 3,199,278 | +2.0% | 0.02% | -5.3% |
| Q3 2018 | $38,891,000 | -12.0% | 3,136,406 | +8.3% | 0.02% | -17.4% |
| Q2 2018 | $44,173,000 | -17.2% | 2,896,530 | +7.8% | 0.02% | -14.8% |
| Q1 2018 | $53,330,000 | +169.4% | 2,686,630 | +153.8% | 0.03% | +200.0% |
| Q4 2017 | $19,796,000 | -5.9% | 1,058,630 | +8.2% | 0.01% | -10.0% |
| Q3 2017 | $21,043,000 | +122.8% | 978,730 | 0.0% | 0.01% | +100.0% |
| Q2 2017 | $9,445,000 | +62.2% | 978,730 | 0.0% | 0.01% | +66.7% |
| Q1 2017 | $5,823,000 | +50.6% | 978,730 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $3,866,000 | -62.3% | 978,730 | 0.0% | 0.00% | -60.0% |
| Q3 2016 | $10,267,000 | -28.1% | 978,730 | 0.0% | 0.01% | -37.5% |
| Q2 2016 | $14,270,000 | -24.2% | 978,730 | 0.0% | 0.01% | -20.0% |
| Q1 2016 | $18,831,000 | -4.6% | 978,730 | +19.7% | 0.01% | 0.0% |
| Q4 2015 | $19,747,000 | +4.1% | 817,330 | +5.7% | 0.01% | +11.1% |
| Q3 2015 | $18,968,000 | +2.9% | 772,930 | -1.7% | 0.01% | +12.5% |
| Q2 2015 | $18,427,000 | +8.5% | 786,630 | +3.9% | 0.01% | 0.0% |
| Q1 2015 | $16,978,000 | +37.1% | 756,930 | +3.0% | 0.01% | +33.3% |
| Q4 2014 | $12,388,000 | – | 734,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |